Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

COMPLETED
Study the Average Aerobic Bioburden Levels on Catheters After Use With Egret Catheter and the Predicate Device
Description

PURPOSE OF EVALUATION: This study will verify \& validate the acceptability of Egret's extended use product as compared to the existing daily change-out product. Based on an extensive in-vitro study, Egret's product confirmed significant kill for both positive and negative gram bacteria. In addition to meeting all of the current product requirements, total aerobic bio-burden on the catheters will be tested at various intervals for up to 10 days of use. The current used product will be used as a control group that is to be changed out daily as per current policy. The control group will be tested for total aerobic bacteria counts on the last day of use.